Skip to main content

Table 2 Perspectives about qualities of the information received on the 13vPCV supplementary dose program from survey respondents (n = 120)

From: Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings

  Agree n (%) Neutral n (%) Disagree n (%)
Timely 93 (77) 7 (6) 21 (17)
Sufficient 102 (86) 8 (7) 8 (7)
Easy to access 101 (87) 11 (10) 4 (3)
Clear 109 (93) 5 (4) 4 (3)